CMP market is perceived as a strategic segment, since gives to European SME such as Cremascoli Ortho a competitive advantage over large, US-based, multinational competitors, less flexible and less close to the end-user. Unfortunately, the design process actually used at Cremascoli Ortho CMP presents two major drawbacks. First, it is rather primitive from a technological point of view requiring excessive human effort which increase the final production cost. Second, the introduction of the new EC rules on medical devices makes inadequate the actual design verification process.
Two are the main results of the HIPCOM project:
- the HIPCOM software which partially automates the CMP design process
- the HIPCOM verification procedure, an HPCN-based FEA method for the evaluation of the endurance of the implant
1998-01-16 / 1999-05-15
programme CEE/framework: ESPRIT, 4PQ